Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2016, XLI/244: 202-204 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2016, XLI/244: 202-204

Title: Treatment of microscopic colitis – what’s new? 

Author: Gonciarz M, Szkudłapski D, Eszyk J, Smagacz J, Kopała M. 

More details

08/244

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Treatment of microscopic colitis – what’s new?


Gonciarz M1, Szkudłapski D1, Eszyk J1, Smagacz J1, Kopała M2.

1Department of Gastroenterology, Main District Hospital, Sosnowiec, Poland; 2Corpora-Med, Medical Rehabilitation Center, Gliwice, Poland

Microscopic colitis (MC) is frequent, although still uncommonly diagnosed, cause of chronic diarrhea. The etiopathology of MC is unknown but this disease has strong influence on patient’s quality of life (measured by health-related quality of life – HRQoL). MC is characterized by microscopic abnormalities in large bowel’s mucosa whereas endoscopic and radiological examination findings are normal. The treatment of MC is an essential social and financial problem due to its frequency in society. Thanks to the results of some controlled research which judged efficiency of some medicines as well as advisory groups recommendations, the MC therapy is nowadays going from empiric to accordance with evidence based medicine.

Key words: microscopic colitis, collagenous colitis, lymphocytic colitis

Pol Med J, 2016; XLI (244); 202–204